Transcriptomic analysis of ROS1+ non-small cell lung cancer reveals an upregulation of nucleotide synthesis and cell adhesion pathways
Source
Frontiers in oncology - ISSN 2234-943X-14 (2024) p. 1-19
Profiling targeted therapy responses in ROS1+ non-small cell lung cancer using genomically engineered patient-derived cell lines
Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Department of Medical Genetics, 2024,308 p.
Implementing CRISPR/Cas9 into the study of anticancer drug resistance
Source
Interdisciplinary cancer research-p. 1-18
A case-control study supports genetic contribution of the PON gene family in obesity and metabolic dysfunction associated steatotic liver disease
Source
Antioxidants - ISSN 2076-3921-13:9 (2024) p. 1-16
Identification of a DLG3 stop mutation in the MRX20 family
Source
European journal of human genetics - ISSN 1018-4813-32 (2024) p. 317-323